Volitionrx (VNRX) Net Income towards Common Stockholders Growth (3y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.19% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 64.73% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.89% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 29.56% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn | 40.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40.43% |
| Sep 30, 2025 | -34.87% |
| Jun 30, 2025 | -28.57% |
| Mar 31, 2025 | -307.67% |
| Dec 31, 2024 | -333.15% |
| Sep 30, 2024 | -408.11% |
| Jun 30, 2024 | -430.08% |
| Mar 31, 2024 | -861.86% |
| Dec 31, 2023 | -616.44% |
| Sep 30, 2023 | -913.74% |
| Jun 30, 2023 | -1,079.48% |
| Mar 31, 2023 | -14.82% |
| Dec 31, 2022 | 26.51% |
| Sep 30, 2022 | 26.34% |
| Jun 30, 2022 | 26.41% |
| Mar 31, 2022 | 26.46% |
| Dec 31, 2021 | 26.35% |
| Sep 30, 2021 | 26.21% |
| Jun 30, 2021 | 26.21% |